The Cancer Bioinformatics group implements analytical approaches on next generation sequencing data to explore the relationship between genotype and phenotype. We focus on cancer genomes and transcriptomes pathognomonic for defects in DNA damage repair, and those that are reflective of the presence of tumour infiltrating lymphocytes. We aim to identify biologically and clinically relevant molecular characteristics and improve disease monitoring and treatment selection, while ultimately moving towards personalised medicine.